CVE-2023-53734: dawa-pharma-1.0 - SQL Injection via Email Parameter
Deferred
Published 04-12-2025Last modified 07-04-2026
Vulnerability summary
CVE-2023-53734 is a high (CVSS 8.7) SQL Injection vulnerability in mayurik dawa-pharma. EPSS estimates a 0.53% chance of exploitation in the next 30 days, higher than 43.9% of scored vulnerabilities. 1 public exploit is recorded.
CVSS score
8.7/10
010
High · v4.0 (CVE.org)EPSS score
0.53%
0%100%
Low · 0.00 pp in 30 daysKEVNot listedNot listed by any tracked catalog.
RansomwareNot flaggedNo ransomware use recorded.
Public exploits1exploit-database
Timeline
- 04-12-2025PublishedVulnerability first disclosed.
- 07-04-2026Last modifiedVulnerability information updated.
Description
dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.
CVSS metrics
2 scores · 2 sources · 1 versionHigh 8.7Preferred score · CVE.org (CNA)
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:NSourcesAll 2 agree
- NVDNIST8.7HighCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
EPSS trend
Probability
0.53%
Chance of exploitation in the next 30 days
Percentile
44%
Versus all other CVEs
30-day change
No change 0.00 pp
From 0.53% on 22-09-2026
22-09-202622-10-2026
Known exploited
Compare KEV catalogsNot in the CISA KEV catalog.
Not in the ENISA CNW catalog.
Not in the CIRCL catalog.
Public exploits
1 founddawa-pharma 1.0-2022 - Multiple-SQLi
Maturity: poc
Weaknesses
CWE · root causeAffected systems
Mayurik1 product
- dawa-pharma1.0-2022
1 vendor · 1 product
References
5 links- www.nu11secur1ty.comProduct
- www.vulncheck.com/advisories/dawa-pharma-10-sql-injection-via-email-parameterThird Party Advisory